塞库金单抗
加药
斑块性银屑病
医学
银屑病
皮肤病科
随机对照试验
内科学
银屑病性关节炎
作者
Kristian Reich,Andreas Körber,Ulrich Mrowietz,Michael Sticherling,Christian Sieder,J. Früh,Teresa Bachhuber
摘要
Most patients achieved PASI 90 response with secukinumab q4w. There was potential benefit of q2w dosing in some suboptimal responders. Continued q4w treatment can improve response even after 16 weeks.
科研通智能强力驱动
Strongly Powered by AbleSci AI